SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Rasmussen Mette)
 

Sökning: WFRF:(Rasmussen Mette) > The Use of HbA1c, G...

The Use of HbA1c, Glycated Albumin and Continuous Glucose Monitoring to Assess Glucose Control in the Chronic Kidney Disease Population Including Dialysis.

Bomholt, Tobias (författare)
Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark,
Adrian, Therese (författare)
Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark,
Nørgaard, Kirsten (författare)
Steno Diabetes Center Copenhagen, University of Copenhagen, Copenhagen, Denmark.
visa fler...
Ranjan, Ajenthen G (författare)
Steno Diabetes Center Copenhagen, University of Copenhagen, Copenhagen, Denmark.
Almdal, Thomas (författare)
Department of Endocrinology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Larsson, Anders (författare)
Uppsala universitet,Klinisk kemi
Vadstrup, Mette (författare)
Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark,
Rix, Marianne (författare)
Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark,
Feldt-Rasmussen, Bo (författare)
Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark,
Hornum, Mads (författare)
Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark,
visa färre...
Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark, Steno Diabetes Center Copenhagen, University of Copenhagen, Copenhagen, Denmark (creator_code:org_t)
2020-12-02
2021
Engelska.
Ingår i: Nephron. Clinical practice. - : S. Karger AG. - 1660-8151 .- 2235-3186. ; 145:1, s. 14-19
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • BACKGROUND: Glycated haemoglobin A1c (HbA1c) has limitations as a glycemic marker for patients with diabetes and CKD and for those receiving dialysis. Glycated albumin is an alternative glycemic marker, and some studies have found that glycated albumin more accurately reflects glycemic control than HbA1c in these groups. However, several factors are known to influence the value of glycated albumin including proteinuria. Continuous glucose monitoring (CGM) is another alternative to HbA1c. CGM allows one to assess mean glucose, glucose variability, and the time spent in hypo-, normo-, and hyperglycemia. Currently, several different CGM models are approved for use in patients receiving dialysis; CKD (not on dialysis) is not a contraindication in any of these models. Some devices are for blind recording, while others provide real-time data to patients. Small studies suggest that CGM could improve glycemic control in hemodialysis patients, but this has not been studied for individual CKD stages.SUMMARY: Glycated albumin and CGM avoid the pitfalls of HbA1c in CKD and dialysis populations. However, the value of glycated albumin may be affected by several factors. CGM provides a precise estimation of the mean glucose. Here, we discuss the strengths and limitations for using HbA1c, glycated albumin, or CGM in CKD and dialysis population. Key Messages: Glycated albumin is an alternative glycemic marker but is affected by proteinuria. CGM provides a precise estimation of mean glucose and glucose variability. It remains unclear if CGM improves glycemic control in the CKD and dialysis populations.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Urology and Nephrology (hsv//eng)

Nyckelord

Chronic kidney disease
Continuous glucose monitoring
Diabetes
Dialysis
Glycated albumin

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy